Background illustration for clinical trials search

Paid Clinical Trials Dayton

Discover 1,190 paid clinical trials in Dayton, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

for
Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma (RCC),
Location: Dayton OH, Kettering OH, Centerville OH, Franklin OH,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06661720

Phase 3, Recruiting

The RAPID - PE Study: RESCUE Advanced Protocol for the Treatment of Pulmonary Embolism

for
Pulmonary Embolism
Location: Dayton OH, Cincinnati OH, Indianapolis IN, Toledo OH,
Sponsor: Thrombolex, Inc.

Sex: All

Age: 0+

Code: NCT06433011

Recruiting

Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

for
Hematopoietic Cell Transplantation Recipient, Leukemia,
Location: Dayton OH, Cincinnati OH, Columbus OH, Indianapolis IN,
Sponsor: Children's Oncology Group

Sex: All

Age: 0+

Code: NCT00736749

Recruiting

Stepped Approach to Reducing Risk of Suicide in Primary Care

for
Suicidal Ideation, Suicide, Attempted, Suicide Prevention
Location: Dayton OH, Miamisburg OH, Hilliard OH, Jackson OH,
Sponsor: Cynthia Fontanella

Sex: All

Age: 12 - 17

Code: NCT06018285

Recruiting

International Pediatric Adrenocortical Tumor Registry

for
Adrenocortical Tumor
Location: Dayton OH, Memphis TN
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 0 - 21

Code: NCT00700414

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Dopamine vs. Norepinephrine for Hypotension in Very Preterm Infants With Late-onset Sepsis

for
Late-Onset Neonatal Sepsis, Extreme Prematurity,
Location: Dayton OH, Windsor, London, Hamilton, Toronto, Ottawa,
Sponsor: Mount Sinai Hospital, Canada

Sex: All

Age: 0

Code: NCT05347238

Recruiting

Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)

for
Cardiac Arrest, Out-Of-Hospital, Hypothermia, Induced,
Location: Dayton OH, Cincinnati OH, Columbus OH, Indianapolis IN,
Sponsor: University of Michigan

Sex: All

Age: 0 - 17

Code: NCT05376267

Recruiting

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: Dayton OH, Cincinnati OH, Indianapolis IN, Lexington KY,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 30

Code: NCT06401330

Phase 3, Recruiting

I-DECIDE After Bronchiolitis Hospitalization

for
Bronchiolitis Acute
Location: Dayton OH, Cincinnati OH, Columbus OH, Indianapolis IN,
Sponsor: Seattle Children's Hospital

Sex: All

Age: 0 - 2

Code: NCT07243652

Recruiting

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

for
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular,
Location: Dayton OH, Cincinnati OH, Columbus OH, Indianapolis IN,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT03126916

Phase 3, Recruiting

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: Dayton OH, Cincinnati OH, Columbus OH, Indianapolis IN,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 30

Code: NCT04546399

Phase 2, Recruiting

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

for
B Acute Lymphoblastic Leukemia
Location: Dayton OH, Cincinnati OH, Columbus OH, Indianapolis IN,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 46

Code: NCT06124157

Phase 2, Recruiting

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

for
Recurrent Langerhans Cell Histiocytosis,
Location: Dayton OH, Columbus OH, Indianapolis IN, Lexington KY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 22

Code: NCT05828069

Phase 2, Recruiting

A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)

for
Stage II Nasopharyngeal Carcinoma AJCC v8,
Location: Dayton OH, Cincinnati OH, Columbus OH, Indianapolis IN,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 21

Code: NCT06064097

Phase 2, Recruiting

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

for
Hematologic Disorder, Bleeding Disorder,
Location: Dayton OH, Cincinnati OH, Columbus OH, Indianapolis IN,
Sponsor: American Thrombosis and Hemostasis Network

Sex: All

Age: 0+

Code: NCT04398628

Recruiting

A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia

for
B Acute Lymphoblastic Leukemia Associated With Down Syndrome,
Location: Dayton OH, Columbus OH, Akron OH, Ann Arbor MI,
Sponsor: Children's Oncology Group

Sex: All

Age: 6 - 39

Code: NCT05702645

Recruiting

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

for
Crohn's Disease
Location: Dayton OH, Indianapolis IN, London, Toronto, Atlanta GA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 2 - 17

Code: NCT05509777

Phase 3, Recruiting

The Pediatric Anesthesia Quality Improvement Project

for
Surgery, Anesthesia, Children
Location: Dayton OH, Cincinnati OH, Akron OH, Ann Arbor MI,
Sponsor: The Society for Pediatric Anesthesia

Sex: All

Age: 0 - 21

Code: NCT00674388

Recruiting

A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

for
Low Grade Astrocytoma, Low Grade Glioma,
Location: Dayton OH, Cincinnati OH, Columbus OH, Indianapolis IN,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 2 - 21

Code: NCT04166409

Phase 3, Recruiting

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: Dayton OH, Cincinnati OH, Columbus OH, Indianapolis IN,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 25

Code: NCT03959085

Phase 3, Recruiting